If the stock market drops sharply, not everyone involved loses money.
Those who are positioned for the decline, either by shorting stocks or options trading, can make a killing.
While volatility is a scary word for investors, markets would not move without it.
We need a certain amount of volatility to be able to buy low and sell high.
What investors need is a plan...
Solar energy isn’t just for tree huggers and ESG investors. It’s one of the fastest spreading renewable energy sources in the world.
In fact, it’s now the third-most prevalent renewable energy source behind hydropower and wind power. Experts forecast solar stocks to spike in value going forward.
And that means investors are fighting to get a piece of the next big solar stock.
The Dow Jones today is expected to jump by triple-digits after a Tuesday quote from President Donald Trump suggested lowering the capital gains tax, and other tax cuts.
The President also continued to put pressure on the Federal Reserve to lower interest rates further.
by Greg Miller
Back in early July, I told my readers that one of the "safer" ways to invest in Canopy Growth was through buying shares of Constellation Brands.
Constellation owns a 38% stake in Canopy, so it has skin in the game and exposure to the cannabis market.
But that's just scratching the surface…
Outside of its stake in Canopy, which is already a huge deal, Constellation is also the maker of Corona and owns whiskey, vodka, and tequila brands. This gives it yet another source of revenue and a defensive moat.
Bottom line, it's truly a force to be reckoned with in the cannabis sector!
However, Constellation is already looking ahead to the future. It has sold off some of its wine brands that retail for under $11 so that management can focus on selling more lucrative adult beverages.
Overall, I believe that this is a stock you can retire on. Why? Constellation is a powerhouse company you'll want to keep in your portfolio on a very long-term basis – because it's only going to grow every year.
With that kind of growth and profit potential, you'll be living a very comfortable retirement.
Now, the stock price did take a bit of a dip in January, but it's been rebounding ever since. And you shouldn't be listening to those newer investors who like to focus on the share price and say it's expensive. If you focus on accumulating shares of a quality company, it will add up over time.
The Dow Jones has lost more than 1,000 points since this time last month, and the S&P 500 is down 2.4% for the same time period.
I'm continuing my close watch of the markets for the week ahead, including some of the most impactful earnings reports that will act as a bellwether for the broader economy. Speaking of which… Despite recovering from last week's losses Monday morning, following Trump's tweet indicating progress in trade talks, the market has been trending down […]
After August’s rocky start, stocks have been rebounding.
And this bounce-back in growth is an enormous boon for penny stocks.
And that’s why we’re bringing you the best penny stocks to buy in August 2019.
by
In last month’s update, I said I wouldn’t be surprised to see gold price at $1,500 before the year is up.
And it only took three weeks to get there.
Now, while there’s potential for some correction along the way, I have reason to believe the price of gold is aimed at $1,600.
But we’ll start with why gold is up $100 in the last month.
by David Zeiler
GlaxoSmithKline doesn't appear to be a top pharmaceutical stock to buy – at least not at first glance.
Its shares have underperformed the global pharma sector by 60% over the past decade.
But since Glaxo got a new CEO in 2017, the company has been on the path to a leaner, more focused company.
And with a high Money Morning Stock VQScore™, GSK is looking very attractive indeed.
The Dow Jones today will build on Monday’s gains.
Markets are responding to news that the U.S. will temporarily allow its semiconductor companies to sell to China’s Huawei Technologies Ltd.
